Purpose
|
Risedronate Sodium, a nitrogen-containing bisphosphonate, inhibits osteoclast-mediated bone resorption and modulates bone metabolism, used in the treatment of osteoporosis.
|
Characteristics
|
Tradename: ACTONEL Source of Compound: synthetic, NE-58095, 10?% aqueous DMSO Target: FPS inhibitor,HAP antagonist Receptor: FPS,HAP Status: USAN
|
Purification
|
All the products are sent with COA, HPLC and NMR inspection report to guarantee the quality.
|
Purity
|
98?%
|
Formula
|
C7H10NNaO7P2
|
Solubility
|
Water 2 mg/mL,DMSO 1 mg/mL
|